Jennifer Sheng

机构：Johns Hopkins University, University of Michigan, Johns Hopkins Medicine, Incyte (United States) · ORCID：0000-0002-3044-285X

发表论文 42 篇 · 总被引 659 次 · h-index 13

代表论文

Population Pharmacokinetics of Ipilimumab in Combination With Nivolumab in Patients With Advanced Solid Tumors (2019 · CPT Pharmacometrics & Systems Pharmacology · 被引 43)
Population Pharmacokinetics of Nivolumab in Combination With Ipilimumab in Patients With Advanced Malignancies (2019 · CPT Pharmacometrics & Systems Pharmacology · 被引 33)
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities (2020 · CPT Pharmacometrics & Systems Pharmacology · 被引 30)
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials (2022 · Journal for ImmunoTherapy of Cancer · 被引 21)
Advancing drug development with “Fit-for-Purpose” modeling informed approaches (2025 · Journal of Pharmacokinetics and Pharmacodynamics · 被引 12)
Changing the drug development and therapeutic paradigm with biologic drug combinations and bispecifics: How to choose between these two approaches? (2022 · Clinical and Translational Science · 被引 7)